Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
Abstract: The natural integration of extremely large antenna arrays (ELAAs) and terahertz (THz) communications can potentially establish Tbps data links for 6G networks. However, due to the extremely ...
Abstract: This paper proposes a concept for a coreless axial flux permanent magnet (CAFPM) generator with a double-sided Halbach array rotor for direct-drive offshore wind turbine applications. The ...
Generate Biomedicines Inc. shares slumped 21% in the company’s trading debut after it raised $400 million in an initial public offering. Shares of the Somerville, Massachusetts-based drug developer ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results